In the lead up to the Australian Federal Budget in May 2023, Australian Health Journal reached out to peak health industry bodies to hear about their priorities, either noted in pre-budget submissions lodged with Federal Government in January 2023 or in recent forums such as the Strengthening Medicare Taskforce.
Others have stated their priorities directly with Federal Government. Through these interviews, AHJ gives a final opportunity to communicate to all health stakeholders, the funding needs for a range of priorities. These range from new models of care to pilots and wholesale, system improvements to building more sustainable workforces to help grow certain sectors of the health system
The Chief Executive Officer of The Australasian College of Paramedicine, John Bruning spoke with Australian Health Journal about the following:
- New models of care proposed for paramedics
- Paramedicine pilot program in the pre-budget submission
- Scope of how paramedics can support General Practice, and guidelines on safety and quality
- Current limitations experienced by paramedics needing to be addressed by Government
Lastly John talks about other priorities he hopes are included in the Federal Budget. These include a longer term, widespread reform view of the health system. There has been an approach where things have been “added on, gaps filled, issues identified” in 3-4 year cycles. John hopes there is a direction taken where health is completely reformed, including in access for regional, remote and 1st nations people. John sees the public needing further guidance and awareness on the health system to support public health literacy.
Finally cultural training is needed to deliver safe and appropriate health care to the range of diverse populations that clinicians serve. This can lead to fulfilling and purposeful workforce, which in itself needs the Government to consider the wellbeing aspects of clinicians during very challenging times in the pandemic.
You Might also like
-
Improved treatment in advanced-stage Hodgkin lymphoma
A global clinical trial successfully reduced toxicity and side effects in advanced stage Hodgkin lymphoma patients by using a modified treatment regimen.
Australian Health Journal spoke with Professor Mark Hertzberg in his role in the ALLG HD10 Clinical Trial and as a former Chair of the Scientific Advisory Committee of the Australasian Leukaemia & Lymphoma Group (ALLG), an organisation involved in improving the treatments and lives of blood cancer patients.
-
Observations in diagnosis and treatment of oral cancer over the past 45 years
Professor Dr.Geoff Sussman holds a position in the Faculty of Medicine, Nursing and Health Sciences Monash University, and is the Adjunct Professor of Wound Care He is a wound consultant at the Wound Clinic Austin Hospital.
-
The role of genomic screening in transforming public health
Dr Jane Tiller is a lawyer, genetic counsellor and public health researcher. She is Ethical, Legal & Social Adviser in Public Health Genomics at Monash University, and a National Health and Medical Research Council Investigator Grant holder. Jane is passionate about the use of genomics to prevent disease, and in delivering equitable access to preventive genetic information at the population level. She is co-lead of DNA Screen, a world-first study piloting the offer of preventive DNA screening to the Australian adult population. DNA Screen has tested over 10,000 young people for genetic high risk of medically actionable conditions such as cancer and heart disease, finding about 2% of participants had genetic high risk. Jane is leading efforts to secure Commonwealth Government funding to expand the DNA Screen program, with the eventual goal of the development of a public health population screening program for disease prevention based on high genetic risk.